|
Premier Whole Body PET Imaging System
PET Advance NXi - Positron Emission
Tomography Scanner
The New GE Advance NXi System includes the Sun Ultra 60 Workstation with the latest
software technologies, and provides excellent image uniformity,
count rate and resolution.
These specifications help quantitative accuracy for better tumor
staging, while the new scaleable reconstruction hardware design,
promotes higher throughput and quicker clinical results. In
addition, the new table and gantry design aid in easing patient
apprehensions, while assuring their comfort.
Case Study
• 50 year old male with left upper lobe NSC
lung cancer involving T1 vertebra.
• Performed restaging FDG imaging after
completing chemo and radiotherapy to assess operability.
• FDG PET scan showed a focus of increased
uptake, much smaller than seen on prior FDG scan, in the site of the
primary tumor at the paravertebral aspect of the left upper lung,
corresponding to a residual mass seen on CT scan.
• There were also several foci of increased
uptake in both hilar regions, localized by CT to the region of hilar
blood vessels with no adenopathy, therefore concluded as
representing post-radiation changes, and not a progression of the
disease.
Advance NXi System:
• Large full-ring detector diameter (60cm)
design & long scannable range (165cm)….excellent for whole
body imaging.
• High 2D and 3D Slice sensitivity for
excellent small lesion detection.
• High Count Rate Capability for short-lived
radiopharmaceutical (O-15, Rb-82, N-13, C-11).
• Quantitative Accuracy for improved Tumor
Staging capabilities.
• Scaleable Reconstruction Hardware… to
meet your clinical and budget needs.
• Field upgradeable to Discovery LS
At GE Medical Systems, our molecular imaging and genomics team is
actively advancing the development and visualization of molecular
markers to aid non-invasive diagnosis and target-and-monitor therapy
With the most extensive portfolio of
high-resolution, high-sensitivity clinical scanners in the industry,
GE delivers comprehensive advanced imaging solutions today, For
tomorrow, we are actively developing imaging capabilities that
combines the latest development in targeted diagnostic chemistry
with advanced informatics.
Together, we can make this vision a reality.
It will come sooner than you think.
|